265 Sheraton Blvd.
Macon, GA 31210
Tel: (478) 746-8626 ext 260
This is a phase 2 study is evaluating drug LY3209590 safety and effectiveness compared to insulin degludec in subjects with type 1 diabetes.
This study is being done to assess the efficacy and safety of tirzepatide compared to dulaglutide in patients with type 2 diabetes and increased cardiovascular risk.
This randomized, double-blind, placebo controlled, parallel group study being done to provide data on the efficacy, safety, tolerability and pharmacokinetics of multiple dose of PF-06882961 in adults with type 2 diabetes mellitus that are inadequately controlled on metformin and/or diet and exercise.
A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease
A Multicentre International Randomized Parallel Group Double-blind Placebo-controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-renal Outcomes in Patients With Chronic KIDNEY Disease
Condition: Kidney Disease